KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Hologic (HOLX) Capital Expenditures (2016 - 2025)

Hologic (HOLX) has disclosed Capital Expenditures for 17 consecutive years, with $14.7 million as the latest value for Q4 2025.

Quarterly Capital Expenditures fell 12.5% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.7 million through Dec 2025, down 14.74% year-over-year, with the annual reading at $58.8 million for FY2025, 18.78% down from the prior year.
Capital Expenditures hit $14.7 million in Q4 2025 for Hologic, up from $13.7 million in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $36.3 million in Q3 2023 to a low of $12.8 million in Q1 2024.
Historically, Capital Expenditures has averaged $19.7 million across 5 years, with a median of $17.8 million in 2023.
Biggest five-year swings in Capital Expenditures: surged 83.33% in 2023 and later plummeted 54.82% in 2024.
Year by year, Capital Expenditures stood at $20.5 million in 2021, then decreased by 22.93% to $15.8 million in 2022, then soared by 43.67% to $22.7 million in 2023, then fell by 25.99% to $16.8 million in 2024, then dropped by 12.5% to $14.7 million in 2025.
Business Quant data shows Capital Expenditures for HOLX at $14.7 million in Q4 2025, $13.7 million in Q3 2025, and $12.8 million in Q2 2025.